Hao Zhang

Director/Board Member presso HaploX Investment Holding Ltd.

46 anni

Consumer Services

Commercial Services

Profilo

Hao Zhang currently works at HaploX Investment Holding Ltd., as Non-Executive Director from 2023.
Mr. Zhang received his graduate degree in 2006 from Tsinghua University and undergraduate degree in 2000 from Fudan University.

Posizioni attive di Hao Zhang

Società	Posizione	Inizio
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Director/Board Member	29/01/2023

Tutte le posizioni attive di Hao Zhang

Formazione di Hao Zhang

Tsinghua University	Graduate Degree
Fudan University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hao Zhang

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Commercial Services